It's hard not to be excited about the potential of
Post# of 15624
(Total Views: 426)
Posted On: 03/16/2017 5:56:30 PM
It's hard not to be excited about the potential of the upcoming product launch as it will be a huge improvement from the past treatments and open the door for more cannabis-based drugs to reach patients in need for all types of conditions. A rising tide raises all ships so to speak.
Competition has Numerous Side Effects (steroid creams, vitamin D3 cream, ultraviolet light, and methotrexate).
I believe the cream will prove to be effective at reducing itching and pain, along with reducing inflammation for suffers of Psoriatic arthritis.
We are extremely happy to see plans are coming through like they announced and planned. The upcoming products are in a the best niche market in the fastest growing industry with proper financing and the business model looks incredible.
Quote:
"Because of its immune-inhibitory potential, THC and related cannabinoids are being considered for the treatment of inflammatory skin diseases."
-https://www.ncbi.nlm.nih.gov/pubmed/23889474
Competition has Numerous Side Effects (steroid creams, vitamin D3 cream, ultraviolet light, and methotrexate).
Quote:
"People undergoing systemic treatment must have regular blood and liver function tests to check for medication toxicities."
-Dogra S, Mahajan R (August 2013). "Systemic methotrexate therapy for psoriasis: past, present and future". Clin Exp Dermatol.
I believe the cream will prove to be effective at reducing itching and pain, along with reducing inflammation for suffers of Psoriatic arthritis.
Quote:
"Psoriatic arthritis affects up to 30% of individuals with psoriasis."
-Jain, Sima (2012). Dermatology : illustrated study guide and comprehensive board review. Springer. pp. 83–87. ISBN 978-1-4419-0524-6.
We are extremely happy to see plans are coming through like they announced and planned. The upcoming products are in a the best niche market in the fastest growing industry with proper financing and the business model looks incredible.
Quote:
"OWC is currently working on two topically-applied cannabinoid studies, one is a cream for psoriatic lesions, which is the first study that Dr. Baruch said will conclude this year. The second study concludes early next year and will test the efficacy of lipid-based cannabis ointment for more penetrative applications such as joint pain and inflammation."
-https://www.hempista.com/2015/one-world-cannabis-topical-cannabis-medicine-research-in-israel/
(2)
(0)OWC Pharmaceutical Research Corp. (OWCP) Stock Research Links
Scroll down for more posts ▼